Institute 2 (ticket)
Adolescent Substance Use and Psychiatric Comorbidity: Real-World Clinical Practice Essentials

This Institute educates child and adolescent psychiatrists about the importance of early identification, and simple and effective interventions for adolescents with comorbid substance use disorders (SUD). These conditions frequently co-occur with mood, anxiety, psychotic, and disruptive behavior disorders. Left untreated, SUD rarely resolve spontaneously, and frequently adversely impact the course of co-occurring psychiatric disorders. Recent advances have helped to better understand the biological underpinnings of SUD and in the development of effective biological and behavioral treatments. Presenters review the relationships between SUD and other adolescent psychiatric conditions; discuss how clinical symptoms of SUD may present in youth diagnosed and receiving treatment for other psychiatric disorders; and provide guidance to clinicians about screening and treatment interventions. With information gained from this Institute, attendees are able to implement practical evidence-based strategies to confidently identify and manage SUD and psychiatric comorbidity in clinical practice.
Wednesday, October 23, 2013: 8:00 AM-4:00 PM
Chairs:
Kevin M. Gray, MD and Iliyan Ivanov, MD
8:00 AM  
Opening remarks
8:15 AM  
2.1
Neurobiology of Substance Use Disorders: Scientific Advances Relevant to the Clinic
Iliyan Ivanov, MD Icahn School of Medicine at Mount Sinai, New York, NY
9:10 AM  
2.2
Commonly Abused Substances: Prevalence, Phenomenology, and Clinical Considerations
Geetha A. Subramaniam, MD National Institute on Drug Abuse Center for Clinical Trials Network, Bethesda, MD
10:05 AM  
Break
10:20 AM  
2.3
Addressing ADHD and Related Disorders in Adolescent Substance Use Disorders
Timothy Wilens, M.D. Massachusetts General Hospital, Boston, MA
11:15 AM  
Lunch (on your own)
12:30 PM  
2.4
Is It Real Or Substance Induced?: Clinical Evaluation, Diagnosis, and Treatment of Co-Occurring Mood Disorders in Adolescents with Substance Use Disorder
Paula Riggs, MD University of Colorado Denver, Denver, CO
1:25 PM  
2.5
Co-Occurrence of Substance Use and Psychotic Disorders in Youth
Robert Milin, MD, FRCPC Royal Ottawa Mental Health Centre, Ottawa, ON
2:20 PM  
Break
2:35 PM  
2.6
Addressing Adolescent Substance Use in Clinical Practice: Practical Evidence-Based Strategies
Kevin M. Gray, MD Medical University of South Carolina, Charleston, SC
3:30 PM  
Panel Discussion: Ask the Experts

Sponsored by the AACAP Substance Abuse and Addiction Committee

See more of: Institute
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.